Company Filing History:
1 out of 14 
1 out of 2 
1 out of 10 Years Active: 2018
Title: Luis Gustavo Pérez Rivas: Innovator in Oncology
Introduction
Luis Gustavo Pérez Rivas is a notable inventor based in Málaga, Spain. He has made significant contributions to the field of oncology, particularly in the area of breast cancer treatment. His innovative work focuses on predicting the risk of tumor recurrence, which is crucial for patient management and treatment strategies.
Latest Patents
Luis Gustavo Pérez Rivas holds a patent titled "Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer." This invention relates to methods for predicting the risk of recurrence of breast tumors by measuring the expression levels of specific miRNAs. The patent outlines a method that involves assessing the expression levels of at least one miRNA from a defined group, including miR-149-5p, miR-10a-5p, miR-20b-5p, miR-30a-3p, and miR-342-5p in tumor samples. A change in the expression level of these miRNAs compared to a control sample indicates a high risk of tumor recurrence. The invention also includes tools and kits designed to facilitate this method.
Career Highlights
Throughout his career, Luis Gustavo Pérez Rivas has worked with prominent organizations such as the Servicio Andaluz de Salud and the Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS). His work in these institutions has allowed him to advance his research and contribute to the field of biomedical science.
Collaborations
Luis has collaborated with esteemed colleagues, including José Lozano Castro and Emilio Alba Conejo. These partnerships have enriched his research and have been instrumental in the development of his innovative ideas.
Conclusion
Luis Gustavo Pérez Rivas is a pioneering inventor whose work in oncology has the potential to significantly impact breast cancer treatment. His patent on miRNA signatures represents a valuable advancement in predicting tumor recurrence, showcasing his dedication to improving patient outcomes.